Table 3.
Disease severity and health-related quality of life scores of AD patients
| Variables | Mean (SD) | Median (Q1-Q3) |
|---|---|---|
| EQ-5D-3L index (− 0.865 to 1) | 0.85 (0.15) | 0.85 (0.80–1.00) |
| EQ-5D-5L index (− 0.848 to 1) | 0.82 (0.22) | 0.89 (0.78–0.97) |
| EQ VAS (0–100) (missing = 1) | 69.15 (20.50) | 75.00 (57.00–85.00) |
| DLQI (0–30) | 13.44 (8.46) | 14.00 (6.00–20.00) |
| Skindex-16 total (0–100) | 56.84 (27.46) | 61.49 (35.64–80.04) |
| Symptoms subscale (0–100) | 62.44 (29.64) | 68.75 (37.50–87.50) |
| Emotions subscale (0–100) | 61.21 (29.18) | 69.05 (40.48–85.71) |
| Functioning subscale (0–100) | 46.87 (31.48) | 46.67 (20.00–74.17) |
| Itching VAS (0–10) (past one month) (missing = 1) | 7.01 (2.92) | 8.00 (5.00–9.00) |
| Sleeping VAS (0–10) (past one month) (missing = 3) | 5.51 (3.53) | 6.00 (2.00–9.00) |
| PtGA VAS (0–10) (missing = 1) | 6.04 (2.74) | 7.00 (4.00–8.00) |
| oSCORAD (0–83) | 35.91 (14.61) | 36.90 (26.60–46.73) |
| EASI (0–72) | 15.76 (11.99) | 14.40 (6.10–21.98) |
| IGA (0–5) | 2.77 (1.04) | 3.00 (2.00–3.00) |
For EQ-5D-3L, EQ-5D-5L and EQ VAS higher scores refer to better health status. For all other measures higher scores represent worse health status
DLQI Dermatology Life Quality Index, EASI Eczema Area and Severity Index, IGA Investigator Global Assessment, oSCORAD objective Scoring Atopic Dermatitis, PtGA VAS Patient’s Global Assessment of disease severity visual analogue scale